Synergy Pharmaceuticals (SGYP +0.7%) files a supplemental New Drug Application (sNDA) with the FDA seeking approval of TRULANCE (plecanatide) to treat adults with irritable bowel syndrome with ...
Synergy CHC (NASDAQ:SNYR) filed to sell 1.28 million shares of common stock. This prospectus is not an offer to sell these securities. Filing Synergy CHC secures retail deals with McKesson Canada and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback